Menu
GWAS Study

Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles.

Hautakangas H, Winsvold BS, Ruotsalainen SE et al.

35115687 PubMed ID
GWAS Study Type
873341 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HH
Hautakangas H
WB
Winsvold BS
RS
Ruotsalainen SE
BG
Bjornsdottir G
HA
Harder AVE
KL
Kogelman LJA
TL
Thomas LF
NR
Noordam R
BC
Benner C
GP
Gormley P
AV
Artto V
BK
Banasik K
BA
Bjornsdottir A
BD
Boomsma DI
BB
Brumpton BM
BK
Burgdorf KS
BJ
Buring JE
CM
Chalmer MA
DB
de Boer I
DM
Dichgans M
EC
Erikstrup C
FM
Färkkilä M
GM
Garbrielsen ME
GM
Ghanbari M
HK
Hagen K
HP
Häppölä P
HJ
Hottenga JJ
HM
Hrafnsdottir MG
HK
Hveem K
JM
Johnsen MB
KM
Kähönen M
KE
Kristoffersen ES
KT
Kurth T
LT
Lehtimäki T
LL
Lighart L
MS
Magnusson SH
MR
Malik R
PO
Pedersen OB
PN
Pelzer N
PB
Penninx BWJH
RC
Ran C
RP
Ridker PM
RF
Rosendaal FR
SG
Sigurdardottir GR
SA
Skogholt AH
SO
Sveinsson OA
TT
Thorgeirsson TE
UH
Ullum H
VL
Vijfhuizen LS
WE
Widén E
VD
van Dijk KW
AA
Aromaa A
BA
Belin AC
FT
Freilinger T
IM
Ikram MA
JM
Järvelin MR
RO
Raitakari OT
TG
Terwindt GM
KM
Kallela M
WM
Wessman M
OJ
Olesen J
CD
Chasman DI
ND
Nyholt DR
SH
Stefánsson H
SK
Stefansson K
VD
van den Maagdenberg AMJM
HT
Hansen TF
RS
Ripatti S
ZJ
Zwart JA
PA
Palotie A
PM
Pirinen M
Chapter II

Abstract

Summary of the research findings

Migraine affects over a billion individuals worldwide but its genetic underpinning remains largely unknown. Here, we performed a genome-wide association study of 102,084 migraine cases and 771,257 controls and identified 123 loci, of which 86 are previously unknown. These loci provide an opportunity to evaluate shared and distinct genetic components in the two main migraine subtypes: migraine with aura and migraine without aura. Stratification of the risk loci using 29,679 cases with subtype information indicated three risk variants that seem specific for migraine with aura (in HMOX2, CACNA1A and MPPED2), two that seem specific for migraine without aura (near SPINK2 and near FECH) and nine that increase susceptibility for migraine regardless of subtype. The new risk loci include genes encoding recent migraine-specific drug targets, namely calcitonin gene-related peptide (CALCA/CALCB) and serotonin 1F receptor (HTR1F). Overall, genomic annotations among migraine-associated variants were enriched in both vascular and central nervous system tissue/cell types, supporting unequivocally that neurovascular mechanisms underlie migraine pathophysiology.

102,084 European ancestry cases, 771,257 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

873341
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Norway, Finland, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.